Pharmaceuticals & Biotechnology Editor | 12/04/2012
In this interview Lesley J Stubbins, Director of Human Biological Sample Management, Secretariat to Pharmacovigilance Centre of Excellence at GSK, speaks to Andrea Charles from Pharma IQ, about significant developments for biological sample management, capability gaps in the field and the future of biobanking.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More